Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip1)

被引:62
|
作者
Kwon, TK [1 ]
Nagel, JE [1 ]
Buchholz, MA [1 ]
Nordin, AA [1 ]
机构
[1] NIA,CLIN IMMUNOL SECT,GERONTOL RES CTR,NATL INST HLTH,BALTIMORE,MD 21224
关键词
cell cycle; T-cell; cdk inhibitor; promoter; cyclin; transcription factors;
D O I
10.1016/S0378-1119(96)00416-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cyclin-dependent kinase inhibitor p27(Kip1) plays an important role in regulating cell-cycle progression. p27(Kip1) directly inhibits the catalytic activity of cyclin/cdks (cyclin-dependent kinase) complexes and/or interferes physically with cyclin/cdks activation by CAK. Interestingly, the expression level of p27(Kip1) mRNA was maximal in resting G(0) T-cells and rapidly declined following anti-CD3 activation. We report here the cloning of p27(Kip1) gene from murine genomic DNA and the functional analysis of the promoter of the p27(Kip1) gene. The gene consists of at least three exons and spans more than 5.6 kb of DNA. Primer extension and nuclease S1 protection analysis revealed two major transcription initiation sites. The promoter region lacked a TATA box but contained potential binding sites for the transcriptional factors including two Spl, CRE, Myb and NFkB located at positions -153, -178, -286, -875, and -1011, respectively. To analyze the regulatory mechanisms controlling p27(Kip1) gene expression, we characterized the 5'-flanking region from nt -1609 to +178. The -326 to -615 region contained positive regulatory elements.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
  • [41] Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity
    Eymin, B
    Sordet, O
    Droin, N
    Munsch, B
    Haugg, M
    Van de Craen, M
    Vandenabeele, P
    Solary, E
    ONCOGENE, 1999, 18 (34) : 4839 - 4847
  • [42] p27(Kip1) overexpression causes apoptotic death of mammalian cells
    Wang, XT
    Gorospe, M
    Huang, Y
    Holbrook, NJ
    ONCOGENE, 1997, 15 (24) : 2991 - 2997
  • [43] Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
    Mahitosh Mandal
    Debdutta Bandyopadhyay
    Thea M Goepfert
    Rakesh Kumar
    Oncogene, 1998, 16 : 217 - 225
  • [44] Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity
    Béatrice Eymin
    Olivier Sordet
    Nathalie Droin
    Béatrice Munsch
    Monika Haugg
    Marc Van de Craen
    Peter Vandenabeele
    Eric Solary
    Oncogene, 1999, 18 : 4839 - 4847
  • [45] Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone
    Shiozawa, T
    Nikaido, T
    Nakayama, K
    Lu, X
    Fujii, S
    MOLECULAR HUMAN REPRODUCTION, 1998, 4 (09) : 899 - 905
  • [46] Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney
    Combs, HL
    Shankland, SJ
    Setzer, SV
    Hudkins, KL
    Alpers, CE
    KIDNEY INTERNATIONAL, 1998, 53 (04) : 892 - 896
  • [47] Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
    Mandal, M
    Bandyopadhyay, D
    Goepfert, TM
    Kumar, R
    ONCOGENE, 1998, 16 (02) : 217 - 225
  • [48] The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy
    Verdoodt, B
    Blazek, T
    Rauch, P
    Schuler, G
    Steinkasserer, A
    Lutz, MB
    Funk, JO
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) : 3154 - 3163
  • [49] Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy
    Li, JM
    Brooks, G
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (03): : H1358 - H1367
  • [50] Induction of p27(Kip1) degradation and anchorage independence by Ras through the MAP kinase signaling pathway
    Kawada, M
    Yamagoe, S
    Murakami, Y
    Suzuki, K
    Mizuno, S
    Uehara, Y
    ONCOGENE, 1997, 15 (06) : 629 - 637